Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 13.04 Delayed Data As of Oct 03 |  +0.07 / +0.54%Today’s Change | 12.75 Today|||52-Week Range 16.39 | -4.33% Year-to-Date |
Latest TAK News | Press Releases
| 3 IPO Stocks That You Want to Own Sep 25 / MotleyFool.com - Paid Partner Content | TAK vs. ZTS: Which Stock Should Value Investors Buy Now? Sep 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 12.97 |
| Today’s open | 13.01 |
| Day’s range | 12.86 - 13.08 |
| Volume | 3,281,524 |
| Average volume (3 months) | 2,511,762 |
| Market cap | $40.1B |
Data as of 4:00pm ET, 10/03/2022
Growth & Valuation
| Earnings growth (last year) | -42.31% |
| Earnings growth (this year) | +29.30% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +5.34% |
| P/E ratio | 29.9 |
| Price/Sales | 1.42 |
| Price/Book | 0.86 |
Competitors
Data as of 4:00pm ET, 10/03/2022
Financials
| Next reporting date | October 27, 2022 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $31.8B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 6.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
